Real-world experience on efficacy and safety of different adjuvant chemotherapy regimens in locoregionally advanced nasopharyngeal carcinoma

Real-world experience on efficacy and safety of different adjuvant chemotherapy regimens in locoregionally advanced nasopharyngeal carcinoma

Objective This study aimed to evaluate the efficacy and toxicity of various adjuvant chemotherapy (AC) regimens for treating locoregionally advanced nasopharyngeal carcinoma.Methods and analysis In this retrospective study, the patients received either intravenous AC regimens (cisplatin–fluorouracil...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jie Chen, Sai-Lan Liu, Qiu-Yan Chen, Lin-Quan Tang, Hai-Qiang Mai, Hui Cheng, Pan Wang, Yi-Fu Li, Yu-Chen Li, Hao-Xiang Long, Jie-Yi Lin, Chun Fung Tse, Bo-Wen Shen, Shan-Shan Guo, Shu-Ming Liang, Li-Ting Liu
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2025-07-01
Series:	BMJ Oncology
Online Access:	https://bmjoncology.bmj.com/content/4/1/e000718.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Two or three cycles of induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma?
by: Lin-Feng Guo, et al.
Published: (2025-08-01)

Long-term outcomes of induction chemotherapy followed by concurrent chemoradiotherapy and adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: a retrospective study
by: Xiaoyan Zhao, et al.
Published: (2024-11-01)

Ten-year survival outcomes of concurrent chemoradiotherapy with or without adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma in the IMRT era: A retrospective cohort study stratified by high- and low-risk profiles
by: Wang-Jian Li, et al.
Published: (2025-09-01)

A nomogram integrating clinical stage and pre-EBV DNA to identify the cycles of induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma
by: Sunqin Cai, et al.
Published: (2025-06-01)

Immunotherapy combined with chemotherapy without locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: two case reports and a literature review
by: Yingna Gao, et al.
Published: (2025-01-01)

Prediction of induction chemotherapy response in locoregionally advanced nasopharyngeal carcinoma based on three pretreatment non-Gaussian diffusion MRI models
by: Huanhuan Ren, et al.
Published: (2025-07-01)

Whether Primary Bone‐Only Oligometastatic Nasopharyngeal Carcinoma Patients Benefit From Radiotherapy to the Bones on the Basis of Palliative Chemotherapy Plus Locoregional Radiotherapy?—A Large‐Cohort Retrospective Study
by: Wan‐Ping Guo, et al.
Published: (2024-11-01)

Radiomic Model Associated with Tumor Microenvironment Predicts Immunotherapy Response and Prognosis in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma
by: Jie Sun, et al.
Published: (2025-01-01)

Cost-effectiveness analysis of sintilimab additional to chemoradiotherapy in high-risk locoregionally advanced nasopharyngeal carcinoma
by: Longjiang She, et al.
Published: (2025-07-01)

Comment on “Ten-year survival outcomes of concurrent chemoradiotherapy with or without adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma in the IMRT era: A retrospective cohort study stratified by high- and low-risk profiles”
by: Erkan Topkan, et al.
Published: (2025-09-01)

AK4 promotes nasopharyngeal carcinoma metastasis and chemoresistance by activating NLRP3 inflammatory complex
by: Sai-Lan Liu, et al.
Published: (2025-07-01)

A Bayesian network meta-analysis of the primary definitive therapies for locoregionally advanced nasopharyngeal carcinoma: IC+CCRT, CCRT+AC, and CCRT alone.
by: Zhan-Jie Zhang, et al.
Published: (2022-01-01)

Ulinastatin in the treatment of radiotherapy-induced oral mucositis in locoregionally advanced nasopharyngeal carcinoma: a phase 3 randomized clinical trial
by: Xuguang Wang, et al.
Published: (2025-03-01)

Long-term results of locoregionally advanced nasopharyngeal carcinoma treated with cisplatin and 5-fluorouracil induction chemotherapy with or without docetaxel in young and middle aged adults
by: Yuming Zheng, et al.
Published: (2025-03-01)

Prevalence of mental disorders and their associations with age at diagnosis and time since diagnosis of nasopharyngeal cancer
by: Wen-Xuan Wang, et al.
Published: (2024-12-01)

Adjuvant chemotherapy with S-1 after curative chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck: Reanalysis of the ACTS-HNC study.
by: Akira Kubota, et al.
Published: (2018-01-01)

Development and validation of the immune signature to predict distant metastasis in patients with nasopharyngeal carcinoma
by: Ze-Xian Liu, et al.
Published: (2020-05-01)

Results of combination treatment using docetaxel in an adjuvant chemotherapy regimen for resectable breast cancer
by: L. V. Bolotina, et al.
Published: (2014-07-01)

Comparative study of safflower yellow adjuvant to conventional treatment regimen and conventional treatment regimen on diabetic nephropathy
by: Yun Liang, et al.
Published: (2024-09-01)

DDAH1 Promotes Cisplatin Chemoresistance in Patients with Locally Advanced Nasopharyngeal Carcinoma via the EGFR‐JAK2‐STAT3 Pathway
by: Jin‐Hao Yang, et al.
Published: (2025-08-01)

Endoplasmic reticulum-localized circular RNA FAM13B restrains nasopharyngeal carcinoma lymphatic metastasis through downregulating XBP1
by: Guo-Dong Jia, et al.
Published: (2025-07-01)

62. Analysis of Adjuvant and Non-Adjuvant Chemotherapy Regimens in an Immunocompetent Triple-Negative Breast Cancer Model: Implications for Treatment Optimization
by: Timothy Olsen, MBA, et al.
Published: (2025-05-01)

Induction chemotherapy plus camrelizumab combined with concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma in non-endemic areas: a phase 2 clinical trial in North China
by: Zhongqiu Wang, et al.
Published: (2025-02-01)

Nanostrategies synergize with locoregional interventional therapies for boosting antitumor immunity
by: Ting Luo, et al.
Published: (2025-09-01)

Second Adjuvant Radioiodine Therapy after Reoperation for Locoregionally Persistent or Recurrent Papillary Thyroid Carcinoma
by: Enrique Cadena-Piñeros, et al.
Published: (2022-12-01)

CACA guidelines for holistic integrative management of adolescent and childhood nasopharyngeal carcinoma
by: Li-Ting Liu, et al.
Published: (2025-07-01)

Effects of oral maintenance chemotherapy and predictive value of circulating EBV DNA in metastatic nasopharyngeal carcinoma
by: Han Zhou, et al.
Published: (2020-04-01)

Towards a truly multimodal pain regimen: putting locoregional analgesia in the acute care surgeon’s toolkit
by: Alexander Coomey Schwed
Published: (2024-11-01)

Tislelizumab as adjuvant therapy following endoscopic surgery for resectable recurrent nasopharyngeal carcinoma: a randomized clinical trial
by: Tian Wang, et al.
Published: (2025-05-01)

Non‐Porous Hydrogel Scaffolds for Locoregional Chemotherapy: A One‐Pot Synthesis Approach
by: Sadik Kaga, et al.
Published: (2025-07-01)

The effectiveness of etoposide-containing chemotherapy regimens in the initial treatment of Hemophagocytic Syndrome in pregnancy
by: Jie Wang, et al.
Published: (2025-12-01)

The impairment of induction chemotherapy for stage II nasopharyngeal carcinoma treated with intensity‐modulated radiotherapy with or without concurrent chemotherapy: A propensity score‐matched analysis
by: YuLin Lai, et al.
Published: (2023-02-01)

Preoperative immune prognostic index predicts the prognosis and postoperative adjuvant chemotherapy benefits of esophageal squamous cell carcinoma after minimally invasive esophagectomy
by: Jin Huang, et al.
Published: (2025-05-01)

Early diagnosis and personalized comprehensive treatment of nasopharyngeal carcinoma based on Epstein-Barr virus-specific markers
by: CHEN Jie, et al.
Published: (2024-09-01)

Concurrent Neoadjuvant Chemotherapy and Radiation in Locally Advanced Breast Cancer: Impact on Locoregional Recurrence Rates
by: Natalie Grindrod, et al.
Published: (2025-02-01)

Long term efficacy of adjuvant chemotherapy in elderly patients with early stage breast cancer assessed through SEER database analysis
by: Sheng Chen, et al.
Published: (2025-07-01)

Concurrent chemoradiotherapy with S-1 versus platinum in the treatment of locoregionally advanced nasopharyngeal carcinoma: a multicenter, retrospective, propensity score-matched analysis
by: Chenbin Bian, et al.
Published: (2024-11-01)

Adjuvant chemotherapy for gastric cancer
by: I. P. Kolesnyk, et al.
Published: (2015-12-01)

Adjuvant Second-Dose Chemotherapy before Surgery for Patients with Locally Advanced Rectal Malignancy Is Not Beneficial: A Systematic Review and Meta-Analysis
by: Min Chen, et al.
Published: (2017-01-01)

ACCELERATED REGIMENS OF ADJUVANT RADIOTHERAPY IN THE TREATMENT OF BREAST CANCER
by: G. V. Afonin, et al.
Published: (2017-09-01)